Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
He had been diagnosed, he said, with hypermobility spectrum disorder, a condition in which ones joints move beyond normal range
PMID 10448529
A 0.1 mL (10-unit) draw then delivers 2 mg GHK-Cu plus 0.4 mg each of BPC-157 and TB-4, for 25 doses per vial
Perfect for athletes and anyone recovering from orthopedic injuries or surgeries
animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists
US$ 23.00
US$ 29.53
US$ 27.02
US$ 28.77
US$ 29.80
US$ 22.09
US$ 25.97
